Last edition
News about "ophthalmology"
ExSight Ventures Invests in RevOpsis Therapeutics to Develop Eye Disease Therapies
RevOpsis is developing a novel class of multi-specific antibody-based treatments designed to address significant unmet needs in ophthalmology, with an initial focus on wet Age-related Macular Degeneration (AMD) and diabetic eye disease.
Ophthalmology | 17/09/2025 | By Dineshwori
Samsung Bioepis Partners with Harrow for US Commercialisation of Ophthalmology Biosimilars
Following the transition of commercial rights from Biogen back to Samsung Bioepis, Harrow will assume full responsibility for the commercialisation of both BYOOVIZ and OPUVIZ biosimilars in the US.
Ophthalmology | 18/07/2025 | By Dineshwori
Antag Therapeutics Names Dr. Joerg Moeller as its Chief Executive Officer
With over 30 years of industry and leadership experience, Dr. Moeller has an impressive track record of successfully leading large global organizations and has built an expansive portfolio by driving strategic growth, regulatory compliance, and fostering innovation.
Ophthalmology | 09/01/2025 | By Aishwarya | 116
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy